Exicure Inc
XCUR
Company Profile
Business description
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
Contact
400 Seaport Court
Suite 102
Redwood CityCA94063
USAT: +1 847 673-1700
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
8
Stocks News & Analysis
stocks
Coinbase Earnings: Weak Cryptocurrency Prices Lead to Lower Trading Volume and Net Losses - Clone
We’ve lowered our fair value estimate of Coinbase stock.
stocks
Higher dividend for ASX member of our income pick list
Management lifted guidance and full-year dividend.
stocks
We expect sales growth to moderate for overvalued ASX share
Shares rallied after results but we see future headwinds.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,182.50 | 22.30 | -0.24% |
| CAC 40 | 8,313.42 | 3.08 | -0.04% |
| DAX 40 | 24,824.28 | 23.37 | 0.09% |
| Dow JONES (US) | 49,500.93 | 48.95 | 0.10% |
| FTSE 100 | 10,511.73 | 38.04 | 0.36% |
| HKSE | 26,705.94 | 138.82 | 0.52% |
| NASDAQ | 22,546.67 | 50.48 | -0.22% |
| Nikkei 225 | 56,566.49 | 239.92 | -0.42% |
| NZX 50 Index | 13,031.62 | 86.29 | -0.66% |
| S&P 500 | 6,836.17 | 3.41 | 0.05% |
| S&P/ASX 200 | 8,958.90 | 20.40 | -0.23% |
| SSE Composite Index | 4,082.07 | 51.95 | -1.26% |